HIV Glasgow 2016 CME Internet Symposium Conference Review




Program Overview
Target Audience
Learning Objectives
Program Faculty
Accreditation Statement
Credit Designation Statement
European Continuous Medical Education Credit
Disclosure of Conflicts of Interest
Instructions for Participation and Credit
Disclosure of Unlabeled Use

Program Overview:

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the HIV Glasgow Drug Therapy Congress (HIV Glasgow 2016). This program consists of three components: (1) CME Internet Symposium: Conference Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters from HIV Glasgow 2016, selected by the expert faculty discussants; (2) Rapid-Fire Review of HIV Drug Therapy/Glasgow 2016: a podcast that provides a brief, audio summary of the most essential data presented at the conference and (3) From Conference to Clinic: Reviewing and Applying Data from HIV Drug Therapy/Glasgow 2016: case-based clinic meetings during which the key data are reviewed, discussed and applied to patient care.

The CME Internet Symposium: Conference Review features five HIV experts reviewing and discussing key presentations on antiretroviral therapy presented at HIV Glasgow 2016. The review and discussion focuses on HIV therapeutic options and developments, including: current treatment and management strategies, algorithms and recommendations, therapies in development, epidemiology, and diagnosis and clinical management of specific patient populations. This activity will enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care. All online components of the program can be accessed at

This program is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. in collaboration with Postgraduate Institute for Medicine. It is not a session created by or presented at HIV Glasgow 2016 and it is not sanctioned by the organizers of HIV Glasgow 2016.

Back to Top

Target Audience: 

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top·

Learning Objectives: 

After completing this activity, the participant should be better able to:

  • Use in a clinical setting findings from key new studies on HIV/AIDS diagnosis, management, and treatment presented at HIV Glasgow 2016
  • Employ the current treatment paradigms in the EU and US for HIV/AIDS, including those supported by studies and data presented at HIV Glasgow 2016, to improve patient care
  • Discuss with patients and colleagues the studies and data on newer therapies for HIV/AIDS presented at HIV Glasgow 2016 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS
  • Discuss application of new guidelines presented at HIV Glasgow 2016 to develop treatment plans that are specific to individual patient needs
Release Date: November 3, 2016
Expiration Date: November 3, 2017
Estimated time to complete this program: 2 hours
Media: Internet
Back to Top

Program Faculty: 

José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain  

Jürgen Rockstroh, MD
Professor of Medicine
Department of Medicine I
University Hospital
Bonn, Germany

Marta Boffito, MD, PhD
St. Stephen's AIDS Trust and Imperial College
Chelsea and Westminster Hospital
London, United Kingdom

Renslow Sherer, MD
Professor of Medicine,
Section of Infectious Diseases and Global Health,
University of Chicago
Chicago, Illinois

Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom

Back to Top

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Back to Top

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

European Continuous Medical Education Credit

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 1.0 ECMEC© Credits are available.

Back to Top

Disclosure of Conflicts of Interest:

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. the Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Jose Arribas, MD:
Consulting Fees: Merck, Gilead
Speakers' bureaus: ViiV, Janssen, AbbVie, BMS, Gilead, MSD

Marta Boffito, MD:
Consulting Fees: Gilead, BMS, ViiV
Contracted Research: Gilead, Janssen, ViiV, BMS
Speakers' bureaus: Gilead, Janssen, ViiV, BMS

Graeme Moyle, MD:
Consulting Fees: Tobira Therapeutics, Gilead, Merck
Speakers' bureaus: Merck, Gilead, BMS
Contracted Research: Merck, Gilead, ViiV
Ownership interest: Tobira

Jürgen Rockstroh, MD:
Consulting Fees: Abbott, AbbVie, BMS, Cipla, Gilead, Janssen, Merck, ViiV
Contacted Research: Gilead

Renslow Sherer, MD:
Consulting Fees: Gilead
Contracted Research: Janssen, Gilead

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, MBA, Director of Continuing Education, Amanda Sewell, MBA, Manager of Continuing Education, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Back to Top

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this activity. During the period, November 3, 2016 through November 3, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 11830. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top




  This activity is supported by an independent educational grant from ViiV Healthcare.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.




Prepare to print

Share this page:

Get link code to this page     

Back to Top